Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
about
Proteasomal degradation of the KLF5 transcription factor through a ubiquitin-independent pathwayAcetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatinRegulation of protein tyrosine kinase signaling by substrate degradation during brain developmentAIMP2/p38, the scaffold for the multi-tRNA synthetase complex, responds to genotoxic stresses via p53Proteasomal Turnover of Hepatitis C Virus Core Protein Is Regulated by Two Distinct Mechanisms: a Ubiquitin-Dependent Mechanism and a Ubiquitin-Independent but PA28 -Dependent MechanismQuercetin as an Emerging Anti-Melanoma Agent: A Four-Focus Area Therapeutic Development StrategyRedox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degronNAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotectorThe NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysisA mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73Impairment of antioxidant defenses as a contributor to arsenite-induced cell transformationFates of retroviral core components during unrestricted and TRIM5-restricted infectionRapid turnover of unspliced Xbp-1 as a factor that modulates the unfolded protein responsep73 as a pharmaceutical target for cancer therapyTP63 and TP73 in cancer, an unresolved "family" puzzle of complexity, redundancy and hierarchy.NAD(P)H quinone-oxydoreductase 1 protects eukaryotic translation initiation factor 4GI from degradation by the proteasome.NAD(P)H quinone oxidoreductase protects TAp63gamma from proteasomal degradation and regulates TAp63gamma-dependent growth arrest.The pancreatic and duodenal homeobox protein PDX-1 regulates the ductal specific keratin 19 through the degradation of MEIS1 and DNA bindingTP53, MDM2, NQO1, and susceptibility to cervical cancer.PIG3 Regulates p53 Stability by Suppressing Its MDM2-Mediated UbiquitinationInhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin.A functional NQO1 609C>T polymorphism and risk of gastrointestinal cancers: a meta-analysis.Ubiquitin-dependent and ubiquitin-independent control of subunit stoichiometry in the SWI/SNF complex.P53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1A functional NQO1 609C>T polymorphism and risk of hepatocellular carcinoma in a Chinese population.Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 proteinInvestigation of 3-aryl-pyrimido[5,4-e][1,2,4]triazine-5,7-diones as small molecule antagonists of β-catenin/TCF transcription.Inhibition of p53-induced apoptosis without affecting expression of p53-regulated genes.Hepatic transcriptomic profiling reveals early toxicological mechanisms of uranium in Atlantic salmon (Salmo salar)Two mutations impair the stability and function of ubiquitin-activating enzyme (E1)The NQO1*2/*2 polymorphism is associated with poor overall survival in patients following resection of stages II and IIIa non-small cell lung cancer.NQO1 Stabilizes p53 in Response to Oncogene-Induced Senescence.Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53.Molecular Analysis of the HOXA2-Dependent Degradation of RCHY1.p53 mediates interstitial cystitis antiproliferative factor (APF)-induced growth inhibition of human urothelial cellsUpregulation of NAD(P)H:quinone oxidoreductase by radiation potentiates the effect of bioreductive beta-lapachone on cancer cells.Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer.The GTPase-deficient Rnd proteins are stabilized by their effectors.Ell3 stabilizes p53 following CDDP treatment via its effects on ubiquitin-dependent and -independent proteasomal degradation pathways in breast cancer cellsAPOBEC3G is degraded by the proteasomal pathway in a Vif-dependent manner without being polyubiquitylated.
P2860
Q24298274-9A47B878-8ADD-460F-828B-6C023871CC44Q24316205-3B22F00B-384A-40D4-82A9-84507AB7A5B1Q24633286-6937A085-FFC0-46D3-B0B6-C9739F17C467Q24644434-1C856324-9D6A-4FF9-A90F-A61254E845E7Q27487945-ACA233AE-E47C-416B-A516-10D1A484E427Q28076840-86641CA7-4E2D-42EC-960D-0D6B73755672Q28261724-B95AA6BE-2CC7-4893-8675-A1D25ED163FAQ28278566-1391047F-B5BA-471C-A188-6451181B350EQ28294622-14B3F93D-FAD5-4EFC-A47F-1104F3F33A92Q28305429-2A272A9B-1811-4070-86E8-FD12037AFC14Q28396493-21D3E9E9-6110-4161-9ADA-AFCD71C6A37BQ28487732-778457C7-4720-4737-95E1-D36A76E68615Q28589998-19B054A4-1006-4A50-A7B2-CA9B656B69A5Q28611414-0B9C7E93-182F-4CBA-85AE-DC2FC342F928Q33358710-3583DBA4-93B1-42EF-ADB4-E59FC5FB12B9Q33627263-271DC6B0-CCE6-4C8E-8522-AA75943B6A60Q33627637-A5801A0F-D641-4041-916E-5F37EF0CB5C1Q33680353-D4401BAD-CA6F-4FD9-B7B6-49546790674EQ33723403-DDF9DF28-C0E0-4B2A-9352-E7858A2CB159Q33878303-54C01116-FBE8-4077-97B5-EE52F7343A62Q33936687-856A6712-A64E-437B-A768-943CAC0E85D2Q34137818-F1C13D7F-6626-4F40-B235-55CE11832F8FQ34285213-92773E33-C6A1-4DA3-A82B-AD5484296684Q34390794-265C679D-C682-47C0-BC18-EE5BBB074A23Q34413452-1B027448-57A1-4187-B2C2-BDD9C8CD0925Q34868376-8A5FCF42-7002-4D7A-B9E5-AF01F49447F7Q34995814-F81707DA-CCE7-4D90-813C-B7D616E0C30EQ35144075-EEB7EAB2-0935-49A6-8108-53D2BBBA91BCQ35229251-0C1CF168-E09E-43D9-82D5-E824880B8CA1Q35250252-3D19537E-DBA3-4736-AF89-DC17C8CC73DFQ35536290-194B87A8-7450-4FD3-9F92-96BFC1A8FBDDQ35739627-DF92CB42-E479-496A-BC24-0598E0BF5683Q35747115-FD42C41F-0E01-45CC-8357-E289BA93F408Q35819036-673BD4C6-C8BD-454F-A8A1-8EEA2B73D386Q35925185-5E7BF073-70F9-420E-99F9-5BF013F1C65BQ35945059-D612BEF6-3F88-4CCE-A89C-ACBE6F6115ADQ36158553-3ED2B717-5102-4CC3-9289-77026E0E22C4Q36234368-CC4F076C-76C4-4BC2-8D2E-A9F3B3B14E3EQ36689029-C0FE2F24-8892-4545-92B2-70E4F8FD1BCFQ36726563-BBD6CA73-D54D-400B-A03A-CD75897E27A5
P2860
Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
@ast
Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
@en
Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
@nl
type
label
Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
@ast
Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
@en
Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
@nl
prefLabel
Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
@ast
Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
@en
Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
@nl
P2093
P2860
P356
P1476
Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
@en
P2093
Chaim Kahana
Joseph Lotem
Yosef Shaul
P2860
P304
13125-13130
P356
10.1073/PNAS.202480499
P407
P577
2002-09-13T00:00:00Z